Finally, treatment with inhibitors of β-secretases, enzymes that cleave APLP2 or APP to release C-terminal fragments, decreased the growth and viability of the pancreatic cancer cell line S2-013 but not of a non-transformed pancreatic ductal cell line. Here, APLP2 is linked to pancreatic neoplasm.